MiR-509-3p and its Role in Gastric Cancer Development
Author Information
Author(s): Jiang Nan, Kang Jiawei, Ding Yi, Shataer Munire, Ma Liangying, Tuersong Tayier
Primary Institution: Xinjiang Medical University
Hypothesis
MiR-509-3p and the p38/MK2 pathway are involved in the malignant progression of gastric cancer.
Conclusion
MiR-509-3p suppresses gastric cancer malignant progression by regulating FOXM1-mediated p38/MK2 pathway activation.
Supporting Evidence
- Overexpression of miR-509-3p suppressed proliferation, migration, and invasion of gastric cancer cells.
- Knockdown of miR-509-3p promoted malignant progression of gastric cancer.
- FOXM1 was identified as a target of miR-509-3p, confirming its role in gastric cancer.
- miR-509-3p overexpression reduced tumor size and weight in vivo.
- miR-509-3p increased apoptosis in gastric cancer cells.
Takeaway
MiR-509-3p helps stop stomach cancer from getting worse by blocking a specific pathway in the cells.
Methodology
The study used various assays including CCK-8, EdU, Transwell, and Western blot analysis to assess the effects of miR-509-3p on gastric cancer cells.
Limitations
The effectiveness of miR-509-3p in clinical applications needs further evaluation.
Participant Demographics
The study involved human gastric cancer cell lines and nude mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website